West Pharmaceutical Services Inc (WST)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 585,500 | 698,000 | 679,900 | 748,900 | 401,300 |
| Revenue | US$ in thousands | 2,893,200 | 2,949,800 | 2,886,900 | 2,831,600 | 2,146,900 |
| Pretax margin | 20.24% | 23.66% | 23.55% | 26.45% | 18.69% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $585,500K ÷ $2,893,200K
= 20.24%
The pretax margin of West Pharmaceutical Services Inc has shown fluctuation over the past five years, from 18.69% in December 2020 to 26.45% in December 2021, before experiencing a slight decline to 23.55% in December 2022. Subsequently, there was a marginal increase to 23.66% in December 2023, followed by a decrease to 20.24% in December 2024. This suggests that the company's ability to generate profits before accounting for taxes has varied, potentially influenced by factors such as changes in revenue, operating expenses, or tax implications. Further analysis of the underlying financial performance and strategic decisions may be helpful in understanding the driving forces behind these fluctuations.
Peer comparison
Dec 31, 2024